[Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications]

Gastroenterol Hepatol. 2000 Dec;23(10):483-90.

[Article in Spanish]

Authors

X Bessa¹, V Piñol, J I Elizalde, A Castells

Affiliation

¹ Servei de Gastroenterologia, Institut de Malalties Digestives, Hospital Clínic, IDIBAPS, Universitat de Barcelona.

PMID: 11149225

No abstract available

Publication types

Review

MeSH terms

Animals
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
Colonic Polyps / drug therapy
Colonic Polyps / enzymology
Colorectal Neoplasms / chemically induced
Colorectal Neoplasms / enzymology
Colorectal Neoplasms / prevention & control*
Cyclooxygenase 2
Enzyme Inhibitors / pharmacology*
Esophageal Neoplasms / enzymology
Humans
Isoenzymes / antagonists & inhibitors
Isoenzymes / physiology*
Membrane Proteins
Mice
Neoplasm Proteins / antagonists & inhibitors
Neoplasm Proteins / physiology*
Prostaglandin-Endoperoxide Synthases / physiology*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Enzyme Inhibitors
Isoenzymes
Membrane Proteins
Neoplasm Proteins
Cyclooxygenase 2
PTGS2 protein, human
Prostaglandin-Endoperoxide Synthases